A pilot randomized controlled trial investigated the efficacy of MAPP, a brief virtual therapy for anxiety during pregnancy. Conducted between Nov 2021 and May 2022, it showed strong participant engagement and significant symptom reduction.
Participants were divided into groups receiving MAPP plus standard care or standard care alone. The study highlights the potential for less resource-intensive treatment options, advocating for further research on this promising approach.
MAPP, developed to offer a feasible alternative, could ease access to psychological support for pregnant patients suffering from anxiety.